Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Sun Yat-sen University
Sun Yat-sen University
Institute of Hematology & Blood Diseases Hospital, China
Rush University Medical Center
Ohio State University Comprehensive Cancer Center
Ontario Clinical Oncology Group (OCOG)
Northwestern University
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital